This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

ARIAD Pharmaceuticals Inc
ARIA : NASDAQ : Health Care

$7.50 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 15,829,500
04/23/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
ARIA ARIAD PHARMACEUTICALS INC 7.10 1321.96 n/m 45.56 8065.05
NPSP NPS PHARMACEUTICALS INC 24.85 2566.11 n/m 155.59 19.09
ACAD ACADIA PHARMACEUTICALS INC 19.28 1879.86 n/m 1.15 -76.67
ACOR ACORDA THERAPEUTICS INC 35.34 1459.93 90.62 336.43 10.01
ARNA ARENA PHARMACEUTICALS INC 6.30 1381.34 n/m 81.39 195.04
PDLI PDL BIOPHARMA INC 8.25 1322.90 4.77 442.92 18.26
CLDX CELLDEX THERAPEUTICS INC 14.69 1312.67 n/m 4.11 -63.31
LGND LIGAND PHARMACEUTICAL INC 62.90 1296.68 149.76 48.97 56.02
AEGR AEGERION PHARMACEUTICALS INC 43.52 1279.97 n/m 48.55 n/a
INSY INSYS THERAPEUTICS INC 36.76 1255.43 31.51 99.29 541.56
IRWD IRONWOOD PHARMACEUTICALS INC 10.61 1240.14 n/m 22.88 -84.78
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ARIA Ind Avg S&P 500
n/m 44.27 18.59

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs